Blood test breakthrough: new way to monitor rare lymphoma
NCT ID NCT06089941
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This study looks at whether a blood test can find tiny bits of tumor DNA in people with a rare blood cancer called peripheral T-cell lymphoma. About 45 patients with new or returning lymphoma will give blood samples to see if the test works well. The goal is to learn if this method can help doctors monitor the disease without needing repeated tissue biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Henri Becquerel
Rouen, France
Conditions
Explore the condition pages connected to this study.